Find News

Filter articles

Applied Filters

Showing 11 to 20 of 225 results

Bayer settles fungicide trade secrets claims

Germany23-12-2019Sarah Morgan

Bayer has dropped trade secrets claims against a former employee and rival company, which it had accused of stealing confidential information related to organic fungicides.

Bausch Health resolves patent litigation with Glenmark

Canada, US23-12-2019Sarah Morgan

Canadian pharmaceutical company Bausch Health and India-based Glenmark Pharmaceuticals have resolved their outstanding IP litigation over Bryhali lotion.

Astellas doubles down on gene therapy with $3bn Audentes deal

Japan, US05-12-2019Sarah Morgan

Astellas is set to buy US-based Audentes Therapeutics for approximately $3 billion, as the Japanese pharmaceutical company looks to boost its gene therapy expertise.

Merck KGaA secures CRISPR patents in Japan and Singapore

Germany, Japan, Singapore27-11-2019Sarah Morgan

The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

Chinese state-owned chemical firm in fungicide patent suit

China, US14-11-2019Rory O'Neill

A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.

Novartis takes aim at Indian drug companies over Entresto generics

India, US29-10-2019Rory O'Neill

Swiss pharmaceutical company Novartis has filed a patent infringement lawsuit against three Indian rivals in a US federal court over proposed generics of its heart failure drug Entresto.

Philippines IP office issues warning over fake drugs

15-10-2019Rory O'Neill

The Philippines’ deputy IP chief has warned e-commerce platforms that they could be made liable for the sale of counterfeit goods on their sites under new legislation, amid fears over the spread of counterfeit pharmaceuticals.

Insilico Medicine signs $200m AI drug discovery deal

10-10-2019Rory O'Neill

Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company.

US biotech licenses antibody from Takeda for new kidney drugs

Japan, US04-10-2019Rory O'Neill

Goldfinch Bio, a US company focused on developing treatments for kidney disease, has agreed to license a cannabinoid receptor 1 antibody from Japanese pharmaceutical manufacturer Takeda.

Taiwanese firm accuses Pacific Biosciences of infringing sequencing tech

Taiwan, US30-09-2019Sarah Morgan

Taiwan-based Personal Genomics Taiwan has taken gene-sequencing rival Pacific Biosciences to court in the US, over alleged patent infringement.

Showing 11 to 20 of 225 results